Certain chromosomal abnormalities have been identified in numerous patients and now serve to define specific cancer diagnoses. For instance, a subtype of acute myeloid leukemia known as acute promyelocytic leukemia is characterized by the translocation between chromosomes 15 and 17.
Our applications have many options that you can customize as you wish.
Determine the most apropriate therapeutic approach for any patient.
Monitor the success of the chosen therapy
Our advanced genetic testing platform has undergone extensive validation in thousands of real-world scenarios, confirming its reliability across a wide range of conditions and applications.
From disease diagnosis to personalized medicine, our platform has been proven to deliver consistent and accurate results, providing peace of mind to both healthcare professionals and patients alike.
With our commitment to excellence and quality assurance, you can trust that our genetic testing platform will meet your highest standards for reliability and accuracy. Experience the difference that thousands of tests performed can make with Ikonisys. Contact us today to learn more.